Patent details

Basic Information

Publication number:

EP2195004

PCT Application Number:

PCT/US/2008/075949

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088309166

PCT Publication Number:

WO/2009/036121

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD OF INHIBITING CLOSTRIDIUM DIFFICILE BY ADMINISTRATION OF ORITAVANCIN

French Title of Invention:

PROCÉDÉ D'INHIBITION DE CLOSTRIDIUM DIFFICILE PAR ADMINISTRATION D'ORITAVANCINE

German Title of Invention:

VERFAHREN ZUR UNTERDRÜCKUNG VON CLOSTRIDIUM DIFFICILE DURCH VERABREICHUNG VON ORITAVANCIN

SPC Number:

Dates

Filing date:

11/09/2008

Grant date:

01/04/2015

EP Publication Date:

01/04/2015

PCT Publication Date:

19/03/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/06/2010

EP B1 Publication Date:

01/04/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/09/2015

Expiration date:

11/09/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/09/2008

 

 

Name:

The Medicines Company

Address:

8 Sylvan Way, Parsippany, NJ 07054, United States (US)

Inventor

1

Name:

WILCOX Mark Harvey

Address:

United Kingdom (GB)

2

Name:

BAINES Simon

Address:

United Kingdom (GB)

3

Name:

PARR Thomas R.

Address:

United States (US)

4

Name:

LEHOUX Dario

Address:

Canada (CA)

Priority

Priority Number:

971766 P

Priority Date:

12/09/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/14;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages